Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

雅培推出新举措以推动医学研究的多样性并改善代表不足人群的护理
  • USA - español
  • USA - Traditional Chinese
  • USA - English

- 雅培正在通过更加重视打破障碍让代表不足群体参与临床试验,来应对健康公平性的关键挑战

- 公司在未来五年为传统黑人院校(HBCU)以及少数族裔护理协会的近300个新设奖学金拨款500万美元,以支持未来几代的多样性临床研究者

- 公司还成立了一个新的研究医学多样性咨询委员会并拨出专用资金,以提高雅培试验中的多样性招募

- 这项最新举措是为公司及其基金会(雅培基金)的工作提供支持的又一项步骤,旨在减少世界各地健康差距


News provided by

Abbott

Nov 04, 2021, 00:31 ET

Share this article

Share toX

Share this article

Share toX

伊利诺伊州雅培科技园2021年11月4日 /美通社/ -- 雅培(纽约证券交易所股票代码:ABT)今天宣布启动一项新举措,旨在通过新的培训教育方法来帮助创建一个更具包容性的临床试验生态系统,改善美国的临床研究基础设施。这项努力建立在雅培的承诺之上,其致力于让过去在医学研究中代表性不足的人群参与进来,将通过增加试验过程中获得创新治疗方案的机会和增进新疗法对不同群体疗效的见解,来改善健康状况。

多元种族和文化背景的人占美国人口的近40%,他们受到心血管疾病和糖尿病等慢性疾病的影响尤其严重。但是,由于历史和社会障碍,这些群体在临床试验中的代表性仍然严重不足——有时仅占试验招募人数的5%。这一差距增加了现有的健康公平性挑战,并限制了患者应对复杂健康状况的选择。

雅培的新举措专注于减少获取障碍,并以公司过去几年在自己的临床试验中重点加强多样性为基础。该举措还支持雅培的2030可持续发展计划,该计划专注于获取和负担能力创新,解决健康差距并消除障碍,以支持其帮助人们过上更全面、更健康生活的目标。

雅培的新举措包括:

  1. 为未来的试验领导者提供资金和奖学金 
    通过与四所HBCU医学院(查尔斯德鲁医科大学、霍华德大学医学院、梅哈里医学院和莫尔豪斯医学院)以及全国黑人护士协会和全国西班牙裔护士协会建立新型合作伙伴关系,雅培已拨出500万美元,在未来五年资助近300个奖学金,以支持下一代将领导和支持未来临床试验的具有种族多样性的护士、医生和研究人员。在临床试验环境中增加医生和护士的多样性也将有助于提高美国多元社区对临床研究的信任。
  2. 研究医学多样性咨询委员会 
    雅培的研究医学多样性咨询委员会(MAB)由领先的独立医生、试验人员和健康倡导者组成,将就如何减少代表不足的人群和有色人种社区获得服务的障碍提供咨询意见,并就雅培如何继续推动某些公司临床试验中的多样性招募提供反馈意见。
  3. 提供专用内部资金以改善雅培试验的获得机会 
    雅培试验中为女性和代表性不足的社区提供专用内部资金以改善获得机会。这笔资金将为某些雅培试验增加试验中心、新调查员培训机会和试验组成部分提供支持,以消除必要时的交通凭证和译员等参与障碍。
  4. 召集行业变革 
    雅培将召集患者利益维护者、行业专家、实验人员和各种各样的医生思想领袖来发展和发布开源视角,以突出围绕在整个医疗科技行业提高临床试验多样性的关键知识。

雅培总裁兼首席执行官Robert B. Ford表示:“最好的保健产品是帮助大多数人并提供最大益处的产品。作为一个行业,我们需要制定新的标准,以确保我们的临床试验仍然在代表我们的产品旨在帮助的人群。我们希望继续打破现有和新出现的参与临床试验的障碍,以便我们能够帮助更多的人获得有可能改变生活的疗法。”

临床研究:未来创新的基础 
临床试验是了解新的医疗器械、诊断测试、医药和疗法如何影响患者健康的最有效方法。它们还代表着有机会治疗对传统疗法无缓解效果的复杂疾病患者。

改善多元人群在临床试验中的代表性,对于减少健康差距和更好地了解下一代医疗保健疗法在所有人口中的影响至关重要。然而,根据美国食品和药物管理局(FDA)的数据,多元种族和文化背景的人以及女性在临床试验中的代表性仍然不足。

在许多社区,几个获得参与的障碍在过去干扰了临床试验的招募,包括无法前往试验中心、试验过程不明确、患者与医生之间缺乏信任和存在语言障碍。此外,缺乏多样性的研究者领导试验中心,以及代表多元社区的研究护士和研究协调员太少,加剧了增加临床研究招募人数的挑战。

莫尔豪斯医学院心脏学家兼医学副教授Melvin Echols博士、美国心脏病学会会员和雅培新成立的研究医学多样性咨询委员会成员表示:“对于那些考虑参加临床试验的人来说,拥有一位长得像他们、会说他们的语言、理解他们和社区需求的医生或护士的重要性怎么强调都不为过。雅培能够利用其在支持有色人种社区试验方面的经验,并开发一个平台来扩大尖端疗法的获取范围,这可以真正改变更多患者的护理延续性。”

创新以提高医疗获得性和促进健康公平性 
雅培推动医学研究多样性的工作就是公司创新以提高医疗获得性和可负担性的一个例子,这是雅培2030可持续发展计划的关键优先事项。 这项工作的一个重要部分是促进健康公平性,与公司所服务的社区并肩工作,解决健康差距,并消除阻碍人们过上健康生活的障碍。

为了取得成果,雅培为此制定了长期目标,并将扩大获得护理的机会作为社区伙伴关系的一项关键原则。这包括开创性的未来幸福社区计划,以消除改善糖尿病护理的社会障碍,支持美国糖尿病协会的健康公平性倡议和Easterseals的黑人儿童基金、芝加哥和奥斯汀与美国心脏协会共同解决高血压问题的当地举措,以及在明尼阿波利斯和芝加哥的新型社区合作伙伴关系。该公司最近还宣布了一项为期三年的合作伙伴关系,作为皇家马德里基金会的全球合作伙伴,为世界各地的高危儿童提供健康和营养教育以及营养不良识别和预防。

要了解有关雅培新推出的临床试验多样性举措的更多信息,请访问inclusiveresearch.abbott

关于雅培: 
雅培作为全球医疗健康行业领导者,帮助人们在生命各阶段生活得更美好。我们为生命健康带来前沿科技,领先产品遍及诊断、医疗器械、营养品、药品等医疗健康领域。10.9万雅培人遍布160个国家/地区,致力于改善全球人们的健康。

在www.abbott.com、LinkedIn(www.linkedin.com/company/abbott-/)、Facebook(http://www.facebook.com/Abbott)和Twitter(@AbbottNews)上联系我们。

Abbott

Related Links

http://www.abbott.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens. The announcement will be...

Abbott Declares 407th Consecutive Quarterly Dividend

Abbott Declares 407th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 407th consecutive...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.